Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Zymeworks (ZYME) Change in Receivables (2021 - 2025)

Zymeworks' Change in Receivables history spans 3 years, with the latest figure at -$47.8 million for Q4 2023.

  • For Q4 2023, Change in Receivables fell 279.2% year-over-year to -$47.8 million; the TTM value through Dec 2023 reached -$13.9 million, down 179.51%, while the annual FY2025 figure was -$51.2 million, 240.82% down from the prior year.
  • Change in Receivables for Q4 2023 was -$47.8 million at Zymeworks, down from $18.5 million in the prior quarter.
  • Across five years, Change in Receivables topped out at $33.5 million in Q1 2023 and bottomed at -$47.8 million in Q4 2023.
  • The 3-year median for Change in Receivables is $2.3 million (2022), against an average of $1.6 million.
  • The largest YoY upside for Change in Receivables was 697.92% in 2023 against a maximum downside of 11886.09% in 2023.
  • A 3-year view of Change in Receivables shows it stood at $10.7 million in 2021, then surged by 149.57% to $26.7 million in 2022, then crashed by 279.2% to -$47.8 million in 2023.
  • Per Business Quant, the three most recent readings for ZYME's Change in Receivables are -$47.8 million (Q4 2023), $18.5 million (Q3 2023), and -$18.1 million (Q2 2023).